Several Biotech Stocks Reach 52-Week Highs
A dpa-AFX report lists biotech stocks that reached 52-week highs on October 12, 2026, including BIIB, HNGE and HSTM.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
A dpa-AFX report lists biotech stocks that reached 52-week highs on October 12, 2026, including BIIB, HNGE and HSTM.
HUM rose 11% and MRNA rose 14% as several biotech stocks reached 52-week highs on October 9, 2026.
Several biotech stocks reached new 52-week highs on October 5, 2026, propelled by positive clinical research data and strong Phase 3 results. Vaxcyte Inc. (PCVX) saw a significant jump of 31%, while INFU and ILMN rose 7%, CRL gained 7%, and HTFL increased by 5%.
Several biotech stocks reached 52-week highs on Sept. 15, 2026, including MediciNova (MNOV), Revvity (RVTY), and Telix (TLX), with the report attributing strength to gains on certain clinical or financial results.